Frequently asked questions
The global Cementless Total Knee Arthroplasty Market was valued at USD 1948.9 Million in 2022.
The Cementless Total Knee Arthroplasty Market is expected to grow at a CAGR of 5.20% between 2023 and 2030, reaching USD 2923.5Million in 2030.
The Younger Patients category dominates market demand in 2022.
Ambulatory surgery centres have the second biggest market share in 2022.
Bone Ingrowth Implants have the greatest Compound Annual Growth Rate (CAGR) in the market.
North America will have the largest revenue share of 41% in the Cementless Total Knee Arthroplasty market in 2022.
The top players include Zimmer Biomet, Smith & Nephew plc, Johnson & Johnson, Corin Group plc, B. Braun Melsungen AG, Waldemar Link GmbH and Co. KG, Stryker Corporation, Group FH Ortho, DePuy Synthes, United Orthopedic Corporation, Microport Scientific Corp. and Others.
The primary drivers of the market include an increase in the number of sports injuries, increased demand due to an aging population, and growing awareness and acceptability
The main factors limiting the growth of Cementless Total Knee Arthroplasty high cost, limited reimbursement policies, and potential difficulties
Increasing demand for minimally invasive procedures, government assistance, and increased use of robotic-assisted knee surgery